ABSTRACT
OBJECTIVES The aim of this analysis was to quantify the relative risk of childhood deaths across the whole of England during the first year of the COVID pandemic, compared to a similar period of 2019.
DESIGN This work is based on data collected by the National Child Mortality Database (NCMD) which collates data on all children who die in England. The number of deaths, and their characteristics, from 1st April 2020 until 31st of March 2021 (2020-21), were compared to those from the same period of 2019-20. Relative risk and excess mortality were derived for deaths in 2020-21 vs 2019-20.
SETTING All deaths reported to NCMD in England of children under 18 years of age, between April 2019 and March 2021.
PARTICIPANTS 6490 deaths of children, under the age of 18 years, reported to the NCMD over the study period.
RESULTS Children who died between April 2020 and March 2021 had similar demographics to those who died in 2019-20. Overall, there were 356 (198 to 514) fewer deaths in 2020-21 than in 2019-20 (RR 0.90 (0.85-0.94), p<0.001). Repeating the analysis by category of death, suggested that deaths from infection (RR 0.49 (0.38-0.64)) and from other underlying medical conditions (RR 0.75 (0.68-0.82)) were lower in 2020-21 than 2019-20, and weak evidence (p=0.074) that this was also true of deaths from substance abuse.
CONCLUSIONS Childhood mortality in England during the first year of the SARS-CoV-2 pandemic was the lowest on record, with over 300 fewer deaths than the preceding 12 months. The greatest reduction was seen in children less than 10 years old. It is important that we learn from this effect, that potentially offers alternative ways to improve the outcome for the most vulnerable children in our society.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The National Child Mortality Database (NCMD) Programme, including this work, is funded by NHS-England and commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Child Mortality Database (NCMD) is set up as a part of statutory duty to record child mortality, with the purpose to investigate health issues in the child population in order to improve population health. The real-time surveillance of child mortality during the COVID-19 pandemic is delivered by the NCMD programme, with the purpose to investigate an outbreak/incident to help in disease control and prevention. This work is classified as Usual Practice in Public Health and Health Protection (https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.hra-decisiontools.org.uk%2Fresearch%2Fdocs%2Fdefiningresearchtable_oct2017-1.pdf&data=04%7C01%7COddD%40cardiff.ac.uk%7C4b07c87fa2c94aeee74c08d9661101dd%7Cbdb74b3095684856bdbf06759778fcbc%7C1%7C0%7C637653046409058252%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=byPZaHhzCBhUdF2u2sIfvVbPc29keBwnCoXi858IFOk%3D&reserved=0) under the UK Policy Framework for Health and Social Care Research, and was reviewed by the Chair of the Central Bristol NHS Research Ethics Committee with confirmation that NHS ethical approval was not required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available to approved parties through application to NCMD
